MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

STERIS PLC

Uždarymo kaina

SektoriusSveikatos priežiūra

225.43 -0.57

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

221.31

Max

227.5

Pagrindiniai rodikliai

By Trading Economics

Pajamos

16M

173M

Pardavimai

42M

1.4B

P/E

Sektoriaus vid.

36.498

63.778

Pelnas, tenkantis vienai akcijai

2.32

Dividendų pajamingumas

1.01

Pelno marža

12.643

Darbuotojai

18,000

EBITDA

-85M

245M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+17.4% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.01%

2.39%

Kitas uždarbis

2025-05-07

Kitas dividendų mokėjimo data

2025-06-25

Kita Ex Dividend data

2025-06-11

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

22B

Ankstesnė atidarymo kaina

226

Ankstesnė uždarymo kaina

225.43

Naujienos nuotaikos

By Acuity

40%

60%

138 / 386 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

STERIS PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-02-05 21:35; UTC

Uždarbis

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

2025-02-05 21:34; UTC

Uždarbis

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

2025-02-05 21:34; UTC

Uždarbis

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

2025-02-05 21:33; UTC

Uždarbis

Steris 3Q EPS $1.75 >STE

2025-02-05 21:30; UTC

Uždarbis

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

2025-02-05 21:30; UTC

Uždarbis

Steris 3Q Rev $1.4B >STE

2025-02-05 21:30; UTC

Uždarbis

Steris 3Q Adj EPS $2.32 >STE

2024-11-06 21:41; UTC

Uždarbis

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

2024-11-06 21:40; UTC

Uždarbis

Steris 2Q EPS $1.51 >STE

2024-11-06 21:30; UTC

Uždarbis

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

2024-11-06 21:30; UTC

Uždarbis

Steris 2Q Adj EPS $2.14 >STE

2024-11-06 21:30; UTC

Uždarbis

Steris 2Q Rev $1.3B >STE

2024-08-06 20:36; UTC

Uždarbis

Steris 1Q Adj EPS $2.03 >STE

2024-08-06 20:30; UTC

Uždarbis

Steris 1Q Net $139.9M >STE

2024-08-06 20:30; UTC

Uždarbis

Steris 1Q EPS $1.41 >STE

2024-08-06 20:30; UTC

Uždarbis

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

2024-06-03 11:03; UTC

Įsigijimai, susijungimai, perėmimai

PEAK ROCK Cap Affil COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION of HUFRIEDYGROUP

2024-05-31 20:47; UTC

Įsigijimai, susijungimai, perėmimai

Steris Completes $787.5M Sale of Dental Segment to Peak Rock Capital

2024-05-08 20:40; UTC

Uždarbis

Steris Sees FY25 Adj EPS $9.05-Adj EPS $9.25 >STE

2024-05-08 20:39; UTC

Uždarbis

Steris: Plan Includes Restructuring of the Healthcare Surgical Business in Europe >STE

2024-05-08 20:39; UTC

Uždarbis

Steris Announcing a Targeted Restructuring Plan >STE

2024-05-08 20:39; UTC

Uždarbis

Steris 4Q EPS $3.81 >STE

2024-05-08 20:30; UTC

Uždarbis

Steris 4Q Adj EPS $2.58 >STE

2024-04-11 11:01; UTC

Įsigijimai, susijungimai, perėmimai

Steris Expects Resulting Benefit of Reduction in Interest Expense to Be About $0.35 Per Shr >STE

2024-04-11 11:00; UTC

Įsigijimai, susijungimai, perėmimai

Steris: Transaction Is Anticipated to Close in 1Q of Fiscal Yr 2025 >STE

2024-04-11 10:59; UTC

Įsigijimai, susijungimai, perėmimai

Steris: Transaction Terms Include Opportunity to Receive Additional Earnout of Up to $12.5M >STE

2024-04-11 10:59; UTC

Įsigijimai, susijungimai, perėmimai

Steris: Transaction Is Structured as Equity Sale >STE

2024-04-11 10:58; UTC

Įsigijimai, susijungimai, perėmimai

Steris Enters Agreement to Divest Dental Segment to Peak Rock Cap for $787.5M >STE

2024-04-11 10:58; UTC

Įsigijimai, susijungimai, perėmimai

STERIS to Sell Dental Segment to an Affiliate of Peak Rock Capital for $787.5M

Akcijų palyginimas

Kainos pokytis

STERIS PLC Prognozė

Kainos tikslas

By TipRanks

17.4% į viršų

12 mėnesių prognozė

Vidutinis 265 USD  17.4%

Aukščiausias 265 USD

Žemiausias 265 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines STERIS PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

2

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

224.21 / 226.14Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bearish Evidence

Vidutinės trukmės periodas

Strong Bullish Evidence

Ilgalaikis periodas

Weak Bullish Evidence

Rinkos nuotaikos

By Acuity

138 / 386 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.